SWEET Rejects Cannabis Oil for Extreme Epilepsy The National Institute for wellness and Care Excellence (SWEET) decided against suggesting cannabis oil cannabidiol (Epidyolex, GW Pharma) with clobazam for treating 2 kinds of serious treatment resistant epilepsy, Dravet, and Lennox-Gastaut syndromes. But, it was said by it wished to assist producer to handle problems highlighted by

Recent Comments